ISTH news and updates: Join the ISTH today – student membership is now free!

ISTH Academy, Faculty / Presenter(s), 290459

In vitro flow based systems to study platelet function and thrombus formation: Recommendations for standardization: Communication from the SSC on Biorheology of the ISTH

ISTH Academy, Mikhail Panteleev, 290460

What the neighbors say

ISTH Academy, Faculty / Presenter(s), 290461

Laboratory monitoring during pregnancy and post‐partum hemorrhage in women with von Willebrand disease

ISTH Academy, Sarah H. O‘Brien, 290462

Response to: Direct oral anticoagulants: Still too early for prime time after pulmonary endarterectomy?

ISTH Academy, Pierre TRINH-DUC, 290463

Antithrombin: An anticoagulant, anti‐inflammatory and antibacterial serpin

ISTH Academy, Sarah H. O‘Brien, 290464

Hemostatic effect of tranexamic acid combined with factor VIII concentrate in prophylactic setting in severe hemophilia A: A preclinical study

ISTH Academy, Yesim Dargaud, 290465

Comparative validation study of risk assessment models for pediatric hospital‐acquired venous thromboembolism

ISTH Academy, Arash Mahajerin, 290466

Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC

ISTH Academy, Paolo Gresele, 290467

Commentary on: Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis: A randomized controlled trial

ISTH Academy, Nicolas Intagliata, 290468

Direct oral anticoagulants: Still too early for prime time after pulmonary endarteriectomy?

ISTH Academy, Laurent Bertoletti, 290469

Acquired Glanzmann thrombasthenia associated with platelet desialylation

ISTH Academy, Shiying Silvia Zheng, 290470

Clinical pre‐test probability adjusted versus age‐adjusted D‐dimer interpretation strategy for DVT diagnosis: A diagnostic individual patient data meta‐analysis

ISTH Academy, Sameer Parpia, 290471

Reply to “Comment on ‘Comparison of three transfusion protocols prior to central venous catheterization in patients with cirrhosis; a randomized controlled trial’”

ISTH Academy, Leonardo L. Rocha, 290474

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel

ISTH Academy, Aleksandra Gasecka, 290475

Patients with aortic stenosis have von Willebrand factor abnormalities and increased proliferation of endothelial colony forming cells

ISTH Academy, Paula James, 290476

Comment on Comparison of three transfusion protocols prior to central venous catheterisation in patients with cirrhosis; a randomised controlled trial

ISTH Academy, Brian J HOGAN, 290477

Response to letter to the Editor: Direct oral anticoagulants in thrombotic antiphospholipid syndrome associated with chronic thromboembolic pulmonary hypertension

ISTH Academy, Pierre TRINH-DUC, 290478

Von Willebrand factor and ADAMTS13 impact on the outcome of Staphylococcus aureus sepsis

ISTH Academy, Peter Verhamme, 290479

May‐Thurner syndrome: History of understanding and need for defining population prevalence

ISTH Academy, Michelle M. Harbin, 290480

Molecular mechanism of two nanobodies that inhibit PAI‐1 activity reveals a modulation at distinct stages of the PAI‐1/plasminogen activator interaction

ISTH Academy, Paul Declerck, 290481

Platelet lipidome: Dismantling the “Trojan horse” in the bloodstream

ISTH Academy, Madhumita Chatterjee, 290482

Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: The Cleveland Clinic experience

ISTH Academy, Dana Angelini, 290483

Increased platelet procoagulant potential predicts recurrent stroke and TIA after lacunar infarction

ISTH Academy, Calin I. Prodan, 290484

The intestinal microbiome potentially affects thrombin generation in human subjects

ISTH Academy, Thijs Van Mens, 290485

Issue Information

ISTH Academy, Faculty / Presenter(s), 290486

Defining trauma‐induced coagulopathy with respect to future implications for patient management: Communication from the SSC of the ISTH

ISTH Academy, Paul Kim, 290487

Validation of the VTE‐BLEED score’s long‐term performance for major bleeding in patients with venous thromboembolisms: From the COMMAND VTE registry

ISTH Academy, Yugo Yamashita, 290490

Hemostasis and anticoagulation in patients with liver dysfunction

ISTH Academy, Armando Tripodi & Nicolas Intagliata, 288304

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

ISTH Academy, Ziyong Sun, 290504

Opening Doors to Open Access Publishing

ISTH Academy, Mary Cushman and Kaia Motter, 288193

Opening Doors to Open Access Publishing

ISTH Academy, Mary Cushman and Kaia Motter, 289244

Physiopathology and treatment of acquired coagulopathies

ISTH Academy, Karim Brohi & Beverly Hunt, 287999

Unaccompanied mechanosensory domain mediates low expression of glycoprotein Ibα: implications for Bernard‐Soulier syndrome

ISTH Academy, Renhao Li, 288004

The prevention and management of asparaginase‐related venous thromboembolism in adults: Guidance from the SSC on Hemostasis and Malignancy of the ISTH

ISTH Academy, Jeffrey Zwicker, 288005

Hemostasis and thrombosis 101—A challenge to energize

ISTH Academy, Faculty / Presenter(s), 288006

Reply to Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with care

ISTH Academy, Daniel Horner, 288007

ISTH news and updates: Join the ISTH today – student membership is now free!

ISTH Academy, Faculty / Presenter(s), 288008

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

ISTH Academy, Robert McBane, 288009

Antigen‐specific in vitro expansion of factor VIII‐specific regulatory T cells induces tolerance in hemophilia A mice

ISTH Academy, Carol H. Miao, 288010

A mathematical model of coagulation under flow identifies factor V as a modifier of thrombin generation in hemophilia A

ISTH Academy, Antonio Formentin, 288011

Reply to: Clinical impact of high platelet count and high hematocrit, by Marc Sorigue

ISTH Academy, Borge Nordestgaard, 288012

Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study

ISTH Academy, Carol H. Miao, 288013

Characterization of the interaction between platelet factor 4 and homogeneous synthetic low molecular weight heparins

ISTH Academy, Carol H. Miao, 288014

Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A

ISTH Academy, Mario Colucci, 288015

Unique surface‐exposed hydrophobic residues in the C1 domain of factor VIII contribute to cofactor function and von Willebrand factor binding

ISTH Academy, Alexander Meijer, 288016

Clinical impact of high platelet count and high hematocrit

ISTH Academy, Marc Sorigue, 288017

What the neighbors say

ISTH Academy, Faculty / Presenter(s), 288018

One piece of the puzzle: Population pharmacokinetics of FVIII during perioperative Haemate P/Humate P treatment in von Willebrand disease patients

ISTH Academy, Marc Sorigue, 288019

Antidepressant drug use and subdural hematoma risk

ISTH Academy, Marc Sorigue, 288020

Efficacy of fibrinogen concentrate in major abdominal surgery – A prospective, randomized, controlled study in cytoreductive surgery for pseudomyxoma peritonei

ISTH Academy, Faheez Mohamed, 288021

Pharmacological thromboprophylaxis to prevent venous thromboembolism in patients with temporary lower limb immobilization after injury: systematic review and network meta‐analysis

ISTH Academy, Daniel Horner, 288022

Ability of a single negative ultrasound to rule out deep vein thrombosis in pregnant women: A systematic review and meta‐analysis

ISTH Academy, Kumait Al Lawati, 288023

Detection of anti‐domain I antibodies by chemiluminescence enables the identification of high‐risk antiphospholipid syndrome patients: A multicenter multiplatform study

ISTH Academy, Katrien Devreese, 288024

Knock‐in mice bearing constitutively active αIIb(R990W) mutation develop macrothrombocytopenia with severe platelet dysfunction

ISTH Academy, Hirokazu Kashiwagi, 288025

Pharmacokinetics, immunogenicity, safety, and preliminary efficacy of subcutaneous turoctocog alfa pegol in previously treated patients with severe hemophilia A (alleviate 1)

ISTH Academy, Clemens Feistritzer, 288026

Validity and reliability of the Colorado Adult Joint Assessment Scale in adults with moderate‐severe hemophilia A

ISTH Academy, Sharon M. Funk, 288027

Thromboprophylaxis in temporary lower limb immobilization: Extrapolate with care

ISTH Academy, Sharon M. Funk, 288028

Inhibition of triggering receptor expressed on myeloid cells‐1 impairs thrombin generation

ISTH Academy, Sébastien Gibot, 288029

Burden of rare exome sequence variants in PROC gene is associated with venous thromboembolism: a population‐based study

ISTH Academy, Weihong Tang, 288030

Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH

ISTH Academy, Peter C. Cooper, 288031

Prevention of venous thromboembolism in medical cancer patients: Guidance or guideline?

ISTH Academy, James Douketis, 288032

Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation

ISTH Academy, Alice Y. Pollitt, 288033

Issue Information

ISTH Academy, Faculty / Presenter(s), 288034

Lupus anticoagulant assay cut‐offs vary between reagents even when derived from a common set of normal donor plasmas

ISTH Academy, Gary Moore, 288035

Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulation

ISTH Academy, Andrew D. Meyer, 288036

Corrigendum

ISTH Academy, Faculty / Presenter(s), 287854

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study

ISTH Academy, Willem Lijfering, 287855

Not all (N)SAID and done: Effects of nonsteroidal anti‐inflammatory drugs and paracetamol intake on platelets

ISTH Academy, Dianne E. van der Wal, 287856

RNA expression and risk of venous thromboembolism in lung cancer

ISTH Academy, Alok Khorana, 287857

The clinical heterogeneity of RUNX1 associated familial platelet disorder with predisposition to myeloid malignancy – A case series and review of the literature

ISTH Academy, Catherine Tang, 287858

Assessing plasminogen activation potential with global fibrinolytic assays

ISTH Academy, Tetsumei Urano, 287859

The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?

ISTH Academy, Katrien Devreese, 287860

A method to determine if more than surrogate outcomes were improved: The EMR glitch experiment

ISTH Academy, Vinay Prasad, 287861

All bleeding matters … but the details may not

ISTH Academy, Sarah OBrien, 287862

Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis

ISTH Academy, Marc Carrier, 287863

Microfluidic hemophilia models using blood from healthy donors

ISTH Academy, Scott L. Diamond, 287864

Looking forward by looking back: Inception of a new journal

ISTH Academy, Mary Cushman, 287865

The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation

ISTH Academy, Julie Rayes, 287866

Bleeding assessment tools to predict von Willebrand disease: Utility of individual bleeding symptoms

ISTH Academy, Paula James, 287867

Development and application of global assays of hyper‐ and hypofibrinolysis

ISTH Academy, Nigel Key, 287868

Modified application of Kawamoto’s film method for super‐resolution imaging of megakaryocytes in undecalcified bone marrow

ISTH Academy, Yosuke Morodomi, 287869

Factor XIII deficiency does not prevent FeCl‐induced carotid artery thrombus formation in mice

ISTH Academy, Alisa Wolberg, 287870

ISSUE INFORMATION

ISTH Academy, Faculty / Presenter(s), 287872

Clinical variables that increase the probability of pulmonary embolism diagnosis in symptomatic children

ISTH Academy, Jeffrey Kline, 287873

A rat model of severe VWD by elimination of the VWF gene using CRISPR/Cas9

ISTH Academy, Robert Montgomery, 287874

Congenital platelet disorders and health status–related quality of life

ISTH Academy, Roger Schutgens, 287875

3D ultrastructural analysis of α‐granule, dense granule, mitochondria, and canalicular system arrangement in resting human platelets

ISTH Academy, Brian Storrie, 287876

Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance

ISTH Academy, Scott Woller, 287877

Paul E. Bock, PhD (21 October, 1949–11 October, 2019)

ISTH Academy, Faculty / Presenter(s), 287589

What the neighbors say

ISTH Academy, Faculty / Presenter(s), 287590

Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro

ISTH Academy, Chunyan Gao, 287591

A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension

ISTH Academy, Mark Toshner, 287592

Screening pulmonary angiogram and the effect on anticoagulation strategies in severe respiratory failure patients on venovenous extracorporeal membrane oxygenation

ISTH Academy, Emma L. Hartley, 287593

Cell type‐specific mechanisms coupling protease‐activated receptor‐1 to infectious colitis pathogenesis

ISTH Academy, Joseph Palumbo, 287605

ISTH News and Updates: Join the ISTH Today – Student Membership is Now Free!

ISTH Academy, Faculty / Presenter(s), 287606

Changes

ISTH Academy, Faculty / Presenter(s), 287607

Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)

ISTH Academy, Ralf Pasternack, 287608

Professor Russell F. Doolittle (1931‐2019)

ISTH Academy, Faculty / Presenter(s), 287609